NOVEL SULFONAMIDE DERIVATIVE HAVING INHIBITORY EFFECT ON EPIDERMAL GROWTH FACTOR RECEPTOR MUTATION

摘要

The present invention relates to the compound represented by the following chemical formula 1, or a pharmaceutical composition for prevention or treatment of cancer having EGFR mutation, the composition comprising the compound and a pharmaceutically acceptable carrier: [chemical formula I].